Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man
References (20)
- et al.
Am. Heart J.
(1958) - et al.
Life Sci.
(1979) - et al.
Life Sci.
(1981) - et al.
Psychiatr. Res.
(1979) - et al.
Life Sci.
(1981) - et al.
Lancet
(1961) - et al.
The Pharmacologic Basis of Therapeutics
(1980) - et al.
Arch. int. Pharmacodyn.
(1968) - et al.
Lancet
(1961) - et al.
J. Neurol. Neurosurg. Psychiatr.
(1977)
There are more references available in the full text version of this article.
Cited by (40)
The effect of substance misuse on HIV persistence in the CNS
2024, HIV-Associated Neurocognitive DisordersMethamphetamine: History, Pathophysiology, Adverse Health Effects, Current Trends, and Hazards Associated with the Clandestine Manufacture of Methamphetamine
2012, Disease-a-MonthCitation Excerpt :The acute adverse effects of such neurotransmitter dysregulation are predominantly because of catecholamine excess. Specifically, this involves cardiovascular activation via norepinephrine release from sympathetic nerve endings as well as psychoactive stimulation from large quantities of DA release into brain synapses, including the caudate, putamen, and ventral striatal regions.11,12 In contrast, chronic methamphetamine use has been shown to cause persistent dopaminergic deficits.
Cortisol effects of d-amphetamine relate to traits of fearlessness and aggression but not anxiety in healthy humans
2006, Pharmacology Biochemistry and BehaviorSympathoadrenal excitation and inhibition by lower brainstem stimulation in cats
1991, Journal of the Autonomic Nervous SystemBiological challenges in obsessive compulsive disorder
1988, Progress in Neuropsychopharmacology and Biological Psychiatry
Copyright © 1983 Published by Elsevier Inc.